CEL-SCI Corporation (CVM) DCF Valuation

CEL-SCI Corporation (CVM) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

CEL-SCI Corporation (CVM) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to assess CEL-SCI Corporation's intrinsic value? Our CVM DCF Calculator integrates real-world data with extensive customization features, enabling you to refine your forecasts and enhance your investment choices.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .5 .6 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 20.73 -100 0 0 -19.82 -19.82 -19.82 -19.82 -19.82
EBITDA -19.6 -26.8 -34.0 -31.7 -27.6 .0 .0 .0 .0 .0
EBITDA, % -4227.21 -4801.69 100 100 100 20 20 20 20 20
Depreciation .6 2.2 .5 3.9 4.0 .0 .0 .0 .0 .0
Depreciation, % 136.9 386.59 100 100 100 100 100 100 100 100
EBIT -20.2 -29.0 -34.5 -35.6 -31.5 .0 .0 .0 .0 .0
EBIT, % -4364.11 -5188.28 100 100 100 20 20 20 20 20
Total Cash 8.4 15.5 42.2 22.7 4.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .1 .1 .1 .0 .0
Account Receivables, % 13.56 9.83 100 100 100
Inventories .8 .8 2.0 2.0 2.2 .0 .0 .0 .0 .0
Inventories, % 169.07 146.79 100 100 100 100 100 100 100 100
Accounts Payable 1.6 2.0 1.7 1.6 2.0 .0 .0 .0 .0 .0
Accounts Payable, % 342.83 362.13 100 100 100 100 100 100 100 100
Capital Expenditure -.3 -2.7 -9.0 -.7 -.4 .0 .0 .0 .0 .0
Capital Expenditure, % -72.57 -482.38 100 100 100 -34.51 -34.51 -34.51 -34.51 -34.51
Tax Rate, % -0.53287 -0.53287 -0.53287 -0.53287 -0.53287 -0.53287 -0.53287 -0.53287 -0.53287 -0.53287
EBITAT -22.5 -30.9 -37.1 -37.1 -31.7 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -21.5 -31.0 -47.2 -33.9 -28.0 .2 .0 .0 .0 .0
WACC, % 6.78 6.78 6.78 6.78 6.78 6.78 6.78 6.78 6.78 6.78
PV UFCF
SUM PV UFCF .2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt 9
Equity Value -9
Diluted Shares Outstanding, MM 44
Equity Value Per Share -0.21

What You Will Get

  • Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: CEL-SCI Corporation’s financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A sleek Excel model that adjusts to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for assessing projections, validating strategies, and enhancing efficiency.

Key Features

  • Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for CEL-SCI Corporation (CVM).
  • WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs specific to CEL-SCI Corporation (CVM).
  • Customizable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates to suit CEL-SCI Corporation (CVM).
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to CEL-SCI Corporation (CVM).
  • Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis of CEL-SCI Corporation (CVM).

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review CEL-SCI Corporation's (CVM) pre-filled financial data and forecasts.
  3. Step 3: Modify critical inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
  5. Step 5: Analyze the outputs and leverage the results for your investment strategies.

Why Choose This Calculator for CEL-SCI Corporation (CVM)?

  • Accurate Data: Utilize real CEL-SCI financials for dependable valuation outcomes.
  • Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
  • Time-Saving: Pre-configured calculations save you from starting from scratch.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Intuitive design and step-by-step guidance ensure accessibility for all users.

Who Should Use This Product?

  • Healthcare Researchers: Explore innovative treatment methodologies and their market implications.
  • Academics: Integrate advanced models into studies or lectures focused on immunotherapy.
  • Investors: Evaluate your own investment strategies and assess potential outcomes for CEL-SCI Corporation (CVM).
  • Market Analysts: Enhance your analysis with a customizable model tailored for biotech companies.
  • Pharmaceutical Entrepreneurs: Understand how established firms like CEL-SCI Corporation (CVM) navigate the market landscape.

What the Template Contains

  • Preloaded CVM Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.